Relationship Between Beta-Blocker and Angiotensin-Converting Enzyme Inhibitor Dose and Clinical Outcome Following Acute Myocardial Infarction-Reference-Cited by-同舟云学术

Relationship Between Beta-Blocker and Angiotensin-Converting Enzyme Inhibitor Dose and Clinical Outcome Following Acute Myocardial Infarction

Published:2015 Issue:3 Volume:79 Page:632-640
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Grall Sylvain¹,Biere Loïc¹,Le Nezet Marie¹,Bouvier Jean-Marc²,Lucas-Chauvelon Pierre³,Richard Claude⁴,Abi-Khalil Wissam¹,Delepine Stéphane¹,Prunier Fabrice¹,Furber Alain¹

Affiliation:

1. Laboratoire Cardioprotection, Remodelage et Thrombose, University of Angers, L’UNAM University and Cardiology Department, University Hospital of Angers

2. Cardiology Department, Hospital of Cholet

3. ardiology Department, Haut-Anjou Hospital

4. Cardiology Department, Hospital of Saumur

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/79/3/79_CJ-14-0633/_pdf

Reference32 articles.

1. 1. Nishino T, Furukawa Y, Kaji S, Ehara N, Shiomi H, Kim K, et al. Distinct survival benefits of angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers in revascularized coronary artery disease patients according to history of myocardial infarction. Circ J 2013; 77: 1242–1252.

2. 2. Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1: First International Study of Infarct Survival Collaborative Group. Lancet 1986; 2: 57–66.

3. 3. GISSI-3: Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction: Gruppo Italiano per lo Studio della Sopravvivenza nell’infarto Miocardico. Lancet 1994; 343: 1115–1122.

4. 4. Ambrosioni E, Borghi C, Magnani B. The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction: The Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators. N Engl J Med 1995; 332: 80–85.

5. 5. Hjalmarson A, Elmfeldt D, Herlitz J, Holmberg S, Malek I, Nyberg G, et al. Effect on mortality of metoprolol in acute myocardial infarction: A double-blind randomised trial. Lancet 1981; 2: 823–827.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Follow-Up After Acute Myocardial Infarction According to Beta-Blocker Dose;The American Journal of Medicine;2023-05

2. Prognostic Impacts of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Acute Coronary Syndrome Patients Without Heart Failure;Frontiers in Pharmacology;2022-04-05

3. Optimal Medical Therapy for Secondary Prevention of Acute Coronary Syndrome: A Retrospective Study from a Tertiary Hospital in Sudan;Therapeutics and Clinical Risk Management;2022-04

4. The Hypertension Paradox: Survival Benefit After ST-Elevation Myocardial Infarction in Patients With History of Hypertension. A Prospective Cohort- and Risk-Analysis;Frontiers in Cardiovascular Medicine;2022-02-24

5. Optimal Dose and Type of β-blockers in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention;The American Journal of Cardiology;2020-12